"Immune Checkpoint Blockade in Cancer Therapy" by Dr. Jim Allison
GLOBAL IMMUNOTALK 05-17-23 In this Global Immunotalk, Dr. Jim Allison focuses on the mechanisms of the immune checkpoints CTLA-4 and PD1, key targets for cancer immunotherapy. He discusses their effects on T cell activation, memory development, and the tumor microenvironment, highlighting the need for fundamental biological understanding to optimize immunotherapy strategies.
▶︎
Immune Checkpoint Blockade in Cancer Therapy
▶︎
Curing metastatic solid tumours with immune checkpoint inhibitors by Professor James Larkin
▶︎
"CD8 T cell fates in cancer and autoimmunity" by Dr. Andrea Schietinger
▶︎
New MRI methods and preclinical models to assess the brain tumor microenvironment | Webinar
▶︎
"Mechanisms of Response and Resistance to Immune Checkpoint Therapy" by Dr. Padmanee Sharma
▶︎
New players in the STING-Interferon pathway of anti-viral and anti-tumor defense by Dr. Sonia Sharma
▶︎
Baim Grand Rounds Katherine Tuttle 15Jun2026
▶︎
The Latest in Immunotherapy to Treat Cancer
▶︎
The Future of Cancer Immunotherapy with Dr. James Allison
▶︎
Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers
▶︎
Targeting Cancer Pathways: Understanding Immune Checkpoints
▶︎
New Study Confirms that Cancer Cells Ferment Glutamine
▶︎
T-Cell Memory and Exhaustion
▶︎
Immuno-oncology: Cold to Hot Tumours
▶︎
CAR T Cells: Beating Cancer with the Immune System
▶︎
PD-L1/PD-1 Cancer Immunotherapy and New Targets - Gordon Freeman, PhD
▶︎
"Regulatory T cells for Immune Tolerance" by Dr. Shimon Sakaguchi
▶︎
Introduction to Immunotherapy (Immunotherapy Documentary Part I)
▶︎
"Cells and pathways in immunity to cancer and infection" by Dr. Caetano Reis e Sousa
▶︎